Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career

Go back to Acadia Pharmaceuticals Announces Planned Year-End Retirement of Elizabeth H.Z. Thompson, Ph.D., Head of Research and Development, Following a Distinguished Career
Acadia Pharmaceuticals, Inc. (NASDAQ: ACAD) Delayed: 22.42 +0.80 (3.70%)
Previous Close $21.62    52 Week High $42.49 
Open $21.64    52 Week Low $16.64 
Day High $22.43    P/E N/A 
Day Low $21.59    EPS $-0.42 
Volume 1,028,961